For prostate cancer, the previous findings showed a marginal trend of decreased risk of incidence despite non‐significance (HR 0.95, 95% CI 0.88–1.03) which was indeed of similar trend to current findings (SHR 0.95, 95% CI 0.91–1.00).
← all excerpts
Long-term use of low-dose aspirin for cancer prevention: A 20-year longitudinal cohort study of 1,506,525 Hong Kong residents.
1
—
—